News & Views

  • Health Cluster Outlines Strategy at Medicen Day
    Christian Lajoux and Stephane Roques (left) presenting at Medicen

Health Cluster Outlines Strategy at Medicen Day

Feb 20 2019 Read 413 Times

Medicen Paris Region, one of Europe's leading health clusters, presented its new strategic priorities during the 3rd Medicen Day Meeting, (Feb 7) which gathered more than 200 stakeholders, including members, partners of the cluster, representatives from the Greater Paris region, the French investment bank bpifrance, the EIT Health European network and others. Medicen has just been selected by the French government to be part of the next phase of French competitiveness cluster development, from 2019 to 2022. The cluster will focus on two areas of expertise: support for member companies for growth in Europe and at an international level and the development of the precision medicine industry in France. Medicen will continue to provide high-end support to its member companies in Europe and internationally, in order to increase their funding and accelerate their development. The cluster will continue to be strongly involved in European projects, for which several members successfully applied. In 2018, Medicen was successful in supporting its members in the call for proposals for phase 2 of the SME Instrument programme, within which 2,500 companies have already been funded, out of 30,000 applicants. In France, out of more than 150 submitted projects, only eight were selected (four in healthcare), including three companies supported by Medicen. The winning companies will receive funding of between €1.5M and €2.5M ($1.7M – $2.8M).

Medicen will also strongly support its members in developing the field of precision medicine and its combined therapeutic solutions. "We are delighted to have been selected for the next phase of the clusters’ development. During our annual meeting we presented our ambitious strategy to our members and partners as well as to representatives of the Greater Paris Region. We strive to be a driving force for excellence in precision medicine and for the development of combined therapeutic solutions," said Stéphane Roques, general manager of the Medicen Paris Region cluster. "By 2022, we will strengthen our support to health entrepreneurs to enable the better and faster transformation of scientific and medical knowledge into economic value and jobs for the French sector.”

Reader comments

Do you like or dislike what you have read? Why not post a comment to tell others / the manufacturer and our Editor what you think. To leave comments please complete the form below. Providing the content is approved, your comment will be on screen in less than 24 hours. Leaving comments on product information and articles can assist with future editorial and article content. Post questions, thoughts or simply whether you like the content.

Post a Comment




Digital Edition

Lab Asia April 2019

April 2019

In This Edition Articles - Mobile Affinity Sorbent Chromatography Of Proteins - Integration of MS and UV Data for Peak Tracking in HPLC Method Development - VMXm takes its First Users 'wher...

View all digital editions

Events

ASMS Conference

Jun 02 2019 Atlanta, GA, USA

Drug Discovery Summit

Jun 10 2019 Berlin, Germany

HPLC 2019

Jun 16 2019 Milan, Italy

Chemspec Europe

Jun 26 2019 Basel, Switzerland

View all events